Efficacy of Pippali Churna in Gridhrasi

Randomized Control Clinical Trial Of Pippali Churna in Gridhrasi

Status

Active, not recruiting

Phases

Phase 1Phase 2

Study type

Interventional

Source

CTRI

Registry ID

CTRI/2020/02/023463

Enrollment

Registered

2020-02-20

Start date

Unknown

Completion date

Unknown

Last updated

2021-11-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: M959- Acquired deformity of musculoskeletal system, unspecified

Interventions

Intervention1: Pippali Churna in Grudhreasi: Pippali Churna 250mg BD along with Eranda Taila 20ml and Gomutra 10ml for 28 days Control Intervention1: Ajmodadi Churna: Ajmodadi Churna 1gm BD

Eligibility

Inclusion criteria

Inclusion criteria: Patients with clinical symptoms like Ruka (Referred pain from sphika to Pada Pradesh)Toda, Stambha,Spandana

Exclusion criteria

Exclusion criteria: 1)Previously diagnosed Congenital abnormalities in lumbar spine 2)Operated for spinal disease 3)Pregnancy 4)Previously Diagnosed T.B.of Spine 5)Accidental trauma

Design outcomes

Primary

Measure	Time frame
To determine the efficacy of Pippali Churna in GridhrasiTimepoint: 24weeks	—

Secondary

Measure	Time frame
To review literature on GridhradiTimepoint: Nil	—

Countries

India

Contacts

Public ContactPooja Ajit Ambekar

Hon.Shree Annasaheb Dange Ayurvedic Medical College and post graduation research centre,ashta

pdeshmukhe@yahoo.co.in7719954457

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026